EPOPROSTENOL vs ERDAFITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
EPOPROSTENOL vs ERDAFITINIB: Safety Overview
| Metric | EPOPROSTENOL | ERDAFITINIB |
|---|---|---|
| Total FAERS Reports | 13,322 | 1,106 |
| Deaths Reported | 2,713 | 315 |
| Death Rate | 20.4% | 28.5% |
| Hospitalizations | 8,838 | 226 |
| Average Patient Age | 49.9 yrs | 66.6 yrs |
| % Female Patients | 78.1% | 37.9% |
| FDA Approval Date | Apr 23, 2008 | Apr 12, 2019 |
| Manufacturer | Mylan Institutional LLC | Janssen Products LP |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Discontinued | Prescription |